Executive Sangjin Kim increases stake to 0.08% via open market purchase of 3,000 shares at KRW 17,869
- Non-registered executive (President) Sangjin Kim purchased 3,000 common shares via open market on 2026.05.15 at an average price of KRW 17,869.
- His holdings increased from 7,000 to 10,000 shares, raising his stake from 0.05% to 0.08%.
- Total outstanding shares remain unchanged at 13,320,000.
- The purchase amount (approx. KRW 53.6 million) is negligible relative to market cap, reflecting a minor insider buy.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
- Company: Samjin Pharmaceutical (005500)
- Submission: Sangjin Kim
- Receipt: 05-21-2026